<DOC>
	<DOCNO>NCT01870206</DOCNO>
	<brief_summary>Polio highly infectious disease cause virus . It invade nervous system , cause total paralysis matter hour . The virus enters body mouth multiplies intestine . Initial symptom fever , fatigue , headache , vomit , stiffness neck pain limb . One 200 infection lead irreversible paralysis ( usually legs ) . Among paralysed , 5 % 10 % die breathing muscle become immobilized . There cure polio , prevent . Polio vaccine , give multiple time , protect child life . Compare newborns immunogenicity safety vaccine OPV produce Birmex compare vaccine OPV produce Sanofi Pasteur , produce Vero cell .</brief_summary>
	<brief_title>Randomized Clinical Trial Evaluate Immunogenicity Safety Mexicans Newborns</brief_title>
	<detailed_description>This randomize clinical trial , include 320 newborn sexes resident state México , 160 newborn receive vaccine OPV Birmex 160 newborn receive vaccine OPV Sanofi Pasteur</detailed_description>
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Newborns baby Weight ≥ 2.5 kg Have receive dos Polio Vaccine Whose parent guardian reside work area Whose parent guardian accept sign write informed consent ( , father guardian ) . Born highrisk pregnancy . Weight ≤ 2.5 kg Presence fever , diarrhea , know immunosuppression , respiratory infection . Treatment immunosuppressant . Having neurological disease . Require receive surgery oropharynx .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Weeks</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Immunogenicity</keyword>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Poliomyelitis</keyword>
	<keyword>Newborn</keyword>
</DOC>